iPierian Inc. to Present Data on Tau Antibody Preclinical Efficacy Study for Alzheimer’s Program at Society For Neuroscience Annual Meeting

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

iPierian, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, announced today that it will make a presentation of a preclinical study from its Tau antibody program at the Society for Neuroscience annual meeting taking place November 9-13, 2013, in San Diego, CA.

Help employers find you! Check out all the jobs and post your resume.

Back to news